Cerus (CERS) Share-based Compensation (2010 - 2026)
Cerus (CERS) posted Share-based Compensation of $5.5 million for Q2 2026, up 12.07% sequentially from $4.9 million in Q1 2026, and down 3.26% YoY from $5.7 million in Q2 2025.
Cerus (CERS) Share-based Compensation (2010 - 2026) Analysis & Trends
Cerus has reported Share-based Compensation for 17 years, with the latest figure at $5.5 million in Q2 2026.
- Quarterly Share-based Compensation fell 3.26% year-over-year to $5.5 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $21.0 million (down 11.41% YoY) and the FY2025 annual result came in at $22.9 million, changed 0.0% from the prior year.
- Share-based Compensation improved to $5.5 million in Q2 2026 per CERS's latest filing, from $4.9 million in the prior quarter.
- Over five years, Share-based Compensation peaked at $7.3 million in Q4 2022 and troughed at $4.0 million in Q3 2023.
- A 5-year average of $5.6 million and a median of $5.7 million in 2023 frame the typical range for Share-based Compensation.
- The sharpest annual moves came in 2023 and 2024: Share-based Compensation plunged 32.42% in 2023, then surged 46.52% in 2024.
- Over 5 years, Share-based Compensation stood at $7.3 million in 2022, then slumped by 32.42% to $4.9 million in 2023, then gained by 12.26% to $5.5 million in 2024, then dropped by 10.48% to $4.9 million in 2025, then rose by 11.55% to $5.5 million in 2026.
- According to Business Quant data, Share-based Compensation over the past three periods registered $5.5 million, $4.9 million, and $4.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 168.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 7.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 87.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 42.20 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 39.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 45.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 94.15 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 12.80 Mn |
| 10 | Cerus | 560.58 Mn | 504.32 Mn | 29.53 Mn | 5.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.50 Mn |
| Jun 30, 2026 | 5.50 Mn |
| Mar 31, 2026 | 4.90 Mn |
| Mar 31, 2026 | 4.90 Mn |
| Dec 31, 2025 | 4.93 Mn |
| Dec 31, 2025 | 4.93 Mn |
| Sep 30, 2025 | 5.62 Mn |
| Sep 30, 2025 | 5.62 Mn |
| Jun 30, 2025 | 5.68 Mn |
| Jun 30, 2025 | 5.68 Mn |
| Mar 31, 2025 | 6.64 Mn |
| Mar 31, 2025 | 6.64 Mn |
| Dec 31, 2024 | 5.50 Mn |
| Dec 31, 2024 | 5.50 Mn |
| Sep 30, 2024 | 5.83 Mn |
| Sep 30, 2024 | 5.83 Mn |
| Jun 30, 2024 | 5.68 Mn |
| Jun 30, 2024 | 5.68 Mn |
| Mar 31, 2024 | 5.86 Mn |
| Mar 31, 2024 | 5.86 Mn |